1.
BMJ Case Rep
; 13(7)2020 Jul 07.
Article
in English
| MEDLINE | ID: covidwho-638342
ABSTRACT
We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.
Subject(s)
Coronavirus Infections , Glucocorticoids/administration & dosage , Immunoglobulins, Intravenous/administration & dosage , Liver Cirrhosis, Alcoholic , Obesity , Pandemics , Pneumonia, Viral , Purpura, Thrombocytopenic, Idiopathic , Adult , Betacoronavirus/isolation & purification , COVID-19 , Comorbidity , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/physiopathology , Humans , Hypoxia/diagnosis , Hypoxia/etiology , Immunologic Factors/administration & dosage , Liver Cirrhosis, Alcoholic/diagnosis , Liver Cirrhosis, Alcoholic/epidemiology , Male , Obesity/diagnosis , Obesity/epidemiology , Oxygen Inhalation Therapy/methods , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/physiopathology , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Purpura, Thrombocytopenic, Idiopathic/etiology , Purpura, Thrombocytopenic, Idiopathic/physiopathology , Purpura, Thrombocytopenic, Idiopathic/therapy , Radiography, Thoracic/methods , SARS-CoV-2 , Tomography, X-Ray Computed/methods , Treatment Outcome
2.
J Hepatol
; 73(4): 967-970, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-610419